T he optimal source of cells for tissue regeneration of the human heart remains controversial. 1, 2 The capacity of the cardiac cKit + cell to form cardiomyocytes in several murine models has recently intensified this controversy by suggesting a relatively low contribution of this cell type to endogenous cardiomyogenesis. [3] [4] [5] [6] Several findings suggest that the cardiomyogenic capacity of this cell may be endogenously suppressed, on the one hand, and may be augmented in a therapeutic situation, on the other. 4, [7] [8] [9] In particular, an increasing number of experimental 7, 8, 10, 11 and clinical studies (NCT02501811) support the idea that therapeutic responses may be substantially augmented by the interaction of 2 cell types: mesenchymal stem cells (MSCs) and cardiac-derived cKit+ cardiac stem cells (CSCs). a novel therapeutic target for enhancing cardiomyogenesis from endogenous CSCs in the postnatal heart.
Methods
An expanded Methods section describing all procedures and protocols is available in the Online Data Supplement.
This study was reviewed and approved by the University of Miami Institutional Animal Care and Use Committee and complies with all Federal and State guidelines concerning the use of animals in research and teaching as defined by The Guide for the Care and use of Laboratory Animals (National Institutes of Health, revised 2011).
The cKit CreERT2/+ and IRG mice have been described elsewhere. 4 Induced pluripotent stem cells (iPSC kit ) were generated from adult cKit CreERT2 /IRG tail-tip fibroblasts as previously described. 4 Genotyping, tamoxifen injections, gene-expression analysis, lineagetracing, and histological analysis were performed as previously described. 4 Manufacturing of human and porcine MSCs and CSCs was performed as previously described.
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Results
MSCs Stimulate Chemotaxis in Postnatal CSCs
To characterize the properties of postnatal CSCs, we pulsed postnatal day 2 (PN2) cKit MSCs comprise a heterogeneous cell mixture of neural crest-and non-neural crest-derived cells 14, 15 that exert stimulatory effects on CSCs. 7, 9, 10, 16, 17 To address whether MSCs stimulate cKit + cell migration, myocardial explants from the same PN3 cKit CreERT2 ;IRG tamoxifen-pulsed hearts were plated either with mitotically arrested porcine MSCs or on gelatin (control), and cell migration was assessed using EGFP epifluorescence ( Figure 2A ). Coculture with MSCs (n=6 neonates) promoted the outgrowth of both EGFP + and the red fluorescent protein variant DsRed-express + cells from myocardial explants ( Figure 2B and 2C) .
Flow cytometric analysis indicated that 60.9±8.2% of cardiac explant-derived cKit + cells were marked by EGFP ( Figure 2D through 2H). Unlike splenic EGFP + cells, which homogenously expressed CD45 + or CD68 + and exhibited a blastlike phenotype ( Figure 2E and 2I), the cardiac EGFP + cardiac explant-derived cells did not express CD45 or CD68 and had a spindle-like morphology ( Figure 2G and 2J), indicating that the EGFP + cardiac explant-derived cells have a distinct nonhematopoietic lineage. Coexpression of Nkx2.5 corroborated the CSC lineage of EGFP + cardiac explant-derived cells ( Figure 3) .
Notably, the spindle-like, Nkx2.5 + in vitro phenotype of postnatal CSCs closely matches the phenotype of the primordial neural crest-derived cKit + cardiac stem cells that we recently described. 4 Collectively, these findings support that the EGFP + cells in the postnatal heart are CSCs. Their migratory capacity is limited in chemotactic responsiveness to the postnatal cardiac stroma but is substantially augmented by MSCs.
Dichotomous Effects of the SDF1/CXCR4 Pathway on CSC Migration and Differentiation
SDF1/CXCR4 signaling participates in the mobilization of CSCs in the heart [18] [19] [20] [21] [22] [23] and plays an important role in cardiac neural crest cell migration. 24 It has also been suggested that the therapeutic effect of MSCs is partly attributed to their rich SDF1α secretion. 18 ,25 Therefore, we tested the hypothesis that the SDF1/CXCR4 pathway underlies the migratory and differentiation effects of MSCs on CSCs.
We first explored whether the SDF1/CXCR4 signaling pathway is normally active in CSCs, during cardiomyogenesis. Accordingly, we utilized a previously described in vitro model of mouse cardiogenesis, 4 whereby embryoid bodies from induced pluripotent stem cells carrying the cKit Figure 4E and 4F), suggesting that activation of the SDF1/CXCR4 signaling pathway plays an important role in the development of cardiomyogenic CSCs.
Next, we tested the role of SDF1/CXCR4 in postnatal CSCs. Myocardial explant culture assays (n=2) were generated as described above, to analyze the emergence of EGFP + cells in the presence or absence of AMD3100, an inhibitor of the SDF1/ CXCR4 axis 18, 26 ( Figure 5A ). Consistent with the previous finding, 18 exposure to AMD3100 did not block outgrowth of the red fluorescent protein variant DsRed-express + cells, but prevented EGFP + CSCs from migrating from the cultured explants in the presence of porcine MSCs, strongly suggesting that the chemotactic effect of MSCs on CSCs is regulated via the SDF1/ CXCR4 signaling pathway ( Figure 5B through 5D) . Moreover, exposure to AMD3100 resulted in a ≈29-fold increase in the rate of CSCs differentiation into spontaneously contracting cardiomyocytes (from 0.57±0.57% to 16.41±4.03% EGFP + beating cells; P=0.0001; Figure 5B ; Online Movie III).
MSCs Promote Expansion of CSCs via the SCF/ cKit Signaling Pathway
We investigated whether the increased abundance of EGFP + cells reflects increased mobilization because of the chemotactic responsiveness of CSCs to MSCs, or to an increase in CSC proliferation. Tamoxifen-pulsed PN3 cKit
CreERT2
;IRG myocardial explant culture assays (n=6) were performed as described above with or without porcine MSCs, and the growth of EGFP + CSCs was continuously quantified using live tissue epifluorescence imaging every other day for 5 days ( Figure 6A Figure 6B ). Intriguingly, in the absence of MSCs, EGFP + cell expansion occurred primarily within the explanted tissue, whereas in the presence of MSCs, CSCs not only proliferated within the explant but also migrated out and expanded freely from the myocardial explants within the MSC feeder layers (Figures 2 and 5) . However, the abundance of CSCs was not significantly affected by the presence of MSCs compared with controls ( Figure 6B ).
We previously showed that the combination of MSC feeders and exogenous SCF, the ligand of cKit, significantly improves the ex vivo propagation of CSCs. 9 Consequently, we investigated whether the SCF/cKit signaling pathway is important for CSC migration and proliferation. Accordingly, tamoxifen-pulsed PN3 cKit
;IRG myocardial explant culture assays were preformed as described above with or without porcine MSCs (n=6), and the growth of EGFP + cells was quantified using live tissue epifluorescence imaging in the presence or absence of recombinant murine SCF ( Figure 6A) . Surprisingly, the presence of both MSCs and exogenous SCF produced a 3. ;IRG neonates (n=6) were pulsed with tamoxifen on PN3 and PN4, and genetic fate-mapping analysis was performed at PN7 ( Figure 7A ). Expression of EGFP was conditional on the expression of both the cKit CreERT2/+ and IRG alleles and did not occur without tamoxifen induction ( Figure 7B ).
A Proportion of Myocardium Is Generated
At PN7, EGFP epifluorescence was detected in all expected cKit-expressing tissues, including blood, skin, testes, intestine, lungs, 4,30-32 kidney ( Figure 7C ), and teeth ( Figure 7D ). Using live tissue imaging, EGFP + cells were visualized throughout the heart, including spontaneously beating cardiomyocytes within the left and right ventricular walls and the ventricular apex, suggesting that a proportion of neonatal cardiac cells expressed cKit at the time of tamoxifen treatment ( Figure 7E ; Online Movies III through VI).
A mean of 76.9.3±4.5 EGFP + cells were detected per heart section analyzed, 20.9±2.4% of which were tropomyosin + ventricular cardiomyocytes (Figure 7F and 7G; Online Movie VII). In addition, 6.5±1.7% of atrial EGFP + cells Figure 7G ). Intriguingly, we detected only 1 EGFP + /Tropomyosin + mononucleated ventricular cardiomyocyte undergoing mitosis in the 2 neonatal mouse hearts in which we quantified cKit-mediated cardiomyogenesis, suggesting that cKit-dependent cardiomyogenesis and cardiomyocyte proliferation represent 2 distinct mechanisms by which the neonatal mouse heart generates cardiomyocytes ( Figure 7F ). In addition, and consistent with our previous finding, 4 
Stimulation of Dilated Cardiomyopathy Human CSCs by Human MSCs
Finally, we sought to investigate the clinical relevance of our neonatal mice and iPSCs findings and tested whether isolated CSCs from chronically diseased human (h) hearts (hCSCs) are chemotactically responsive to hMSCs, under both normal and hypoxic conditions. We prepared hCSCs from 3 dilated cardiomyopathy patients admitted to our center, after percutaneous endomyocardial biopsy as previously described. 8 We used 3 hMSCs lines previously established in our laboratory from healthy donors (Online Figure IVA) . 13 Flow cytometric analysis indicated that 98.85±0.5% of human CSCs expressed cKit (Online Figure IVB through IVD) . In addition, similar to mouse CSCs, hCSCs expressed Nkx2.5 and the neural crest-specific marker Pax3 (Online Figure IVE and IVF) . A fluo-8 intracellular Ca 2+ mobilization-based assay of CXCR4 activity, with a Chem-1 cell line transduced to overexpress human CXCR4 the and the G protein Gα15, illustrated activation of the human SDF1/CXCR4 pathway by hMSCs; and that this effect is blocked in the presence of 1 μmol/L AMD3100 (data not shown).
The migratory capacity of hCSCs was tested in a transwell migration assay. Accordingly, 1×10 5 hCSCs were suspended in serum-free medium and loaded into the upper wells of Boyden chambers. To test hCSC chemotactic responsiveness to hMSCs, the lower wells of the Boyden chambers were coated 24 hours earlier with 1×10 5 mitotically inactivated hMSCs in serum-free medium. hCSCs were allowed to migrate for 24 hours, in either 20% O 2 or 0.5% O 2 (Online Figure VA) . Quantification of the migrated cells corroborated a marked increase in hCSCs mobilization by hMSCs. The chemotactic effect of hMSCs was abrogated in the presence of AMD3100 (Online Figure VB through VE). Interestingly, exposure of the cell cultures to 0.5% O 2 resulted in acute loss of the migratory activity of hCSCs, which could be partially rescued in the presence of hMSC (Online Figure VE) . Gene-expression analysis illustrated that exposure of hCSCs and hMSCs to hypoxia did not affect the expression of CXCR4, which was highly expressed in hCSCs but not in hMSCs (Online Figure VF) , but resulted in a significant downregulation of SDF1α expression, both in hCSCs and hMSCs (Online Figure VG) .
Discussion
A major hypothesis in the field of cell-based therapy is that different cell types from different tissue origins can have additive effects on tissue repair. One particular promising example is that of cKit + CSCs and MSCs, a concept that has formed the basis for several clinical trials, including the CONCERT-HF (Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart Failure trial). [7] [8] [9] [10] 16, 17, [33] [34] [35] Here, we have uncovered the signaling mechanisms responsible for these interactions. We have shown that SDF1α and SCF secreted by bone marrow-derived MSCs have important effects on CSCs. SDF1α promotes migration of cardiac-derived CSCs and enhances their lineage commitment toward contractile cardiac myocytes, whereas the cKit receptor activation by SCF plays an important role in CSC proliferation (Online Figure I ). These data provide the mechanistic basis by which MSCs activate endogenous CSCs to migrate, proliferate, differentiate, and stimulate repair in the diseased heart.
Our data are in agreement with earlier studies documenting that cell-cell interactions between MSCs and CSCs are associated with enhanced regeneration and therapeutic benefit. 9, 10, [16] [17] [18] 25, 36 We previously showed in a large animal model of myocardial infarction that transplantation of MSCs produces significant improvements in heart function and scar size reduction and that this effect is partly attributed to a transient mobilization of CSCs at the sites of MSCs engraftment. 9 Furthermore, we 7, 8 and others 10 recently showed that when MSCs and CSCs are cotransplanted as a cell mixture, the therapeutic benefit may be further enhanced.
Here, we have used several in vivo and ex vivo sophisticated experimental models, to test these cellular interactions. Our ex vivo genetic lineage-tracing studies, and our experiments with human CSCs and MSCs, document a chemotactic effect of MSCs on CSCs that relies on the SDF1/CXCR4 signaling pathway. Although our transwell experiments with human CSCs and MSCs indicate that direct cell-cell interactions between MSCs and CSCs are not necessary for in vitro chemotaxis, experiments in large animal models of ischemic heart disease show that administering the MSC secretome is not a therapeutically sufficient substitute for MSC transplantation. 9 Accordingly, these data do not exclude cell-cell effects, in addition to paracrine effects, as the underlying mechanisms of cell-based therapies.
We observed that MSCs significantly enhance CSC growth rates in the presence of SCF. Not only based on previous reports 23, 37 but also based on the white-spotting phenotype that is often produced from mutations in the cKit and SCF loci, we expected that the SCF/cKit signaling pathway would Figure III) , suggesting that the observed effect is unlikely because of an underlying cKit haploinsufficiency. Notably, consistent with our findings, a recent study reported that the activation of SCF/cKit signaling alone is not sufficient to regulate CSC migration and requires transactivation of SDF1/CXCR4. 23 A recent report showed that Ephrin signaling also regulates CSC-trafficking CSC. 38, 39 MSCs express Ephrins 40 ; therefore, it is possible that part of the chemotactic effects of MSCs on CSCs that were documented in this study are Ephrin mediated. Interestingly, developmental studies indicate that the 2 signaling pathways may control different aspects of cardiac neural crest cell migration. 41 Signaling through Ephrins has been suggested to provide directional guidance, whereas SDF1/CXCR4 is thought to regulate motility of cardiac neural crest cells. Our findings suggest that SDF1/CXCR4-mediated inhibition of CSC migration may be required for triggering differentiation into cardiomyocytes. It would be interesting to explore whether MSCs could also enhance directional guidance of CSCs into the damaged myocardium via ephrin-mediated signaling.
Using the cKit CreERT2/+ ;IRG reporter mouse line, we were able to track the fate of cKit + cells in the heart (≈60% EGFP + ). Using the same knockin mouse line, we recently delineated a neural crest-derived cardiomyogenic CSC lineage as a source of a relatively small proportion of embryonic cardiomyocytes. 4 Our findings strongly suggest that, as with its embryonic cardiomyogenic cell program, [3] [4] [5] the mammalian heart differentiates a relatively small proportion of postnatal CSCs, to establish its full complement of cardiomyocytes after birth. 27, 42 The postnatal CSCs represent a migratory population of Nkx2.5 + cells whose migration and differentiation are modulated by the SDF1/CXCR4 signaling pathway and can be significantly stimulated by MSCs for therapeutic purposes (Online Figure I) .
Consistent with the fate of the embryonic CSC lineage, 4, 12 our postnatal studies found no evidence for coronary vascular cell labeling under the cKit CreERT2/+ allele. Although this finding seems to contrast with other recent cKit lineage-tracing studies, 3, 5, 6 we think that this discrepancy reflects an apparent lower fate-mapping sensitivity of the cKit CreERT2/+ mouse compared with the other 6 cKit knockin models. 12 Apparently, although all 7 cKit knockin alleles [3] [4] [5] [6] exhibit similar sensitivity in tracing cKit-derived cardiomyocytes, 12, 43 the cKit CreERT2/+ allele specifically marks the cardiomyogenic over the vasculogenic postnatal cKit + lineages because if they were of same ancestry, we should have detected at least a few vascular derivatives with the cKit CreERT2/+ allele. We also examined whether the expression of reporter genes in cardiomyocytes indicates CSC differentiation 3, 4, 44, 45 or in situ expression of cKit in cardiomyocytes. 6 Our in vitro experiments with cells derived from mice with the cKit CreERT2/+ allele show that expression of reporter genes marks noncontractile, proliferative, and migratory cKit + cells, and not differentiated cardiomyocytes. These findings are consistent with previous reports. 3, 4, 44, 46 Nonetheless, because of the apparently lower cardiac sensitivity of the cKit CreERT2/+ allele compared with other cKit knockins, 5, 6 we do not exclude the possibility that a population of cardiomyocytes, undetectable by our reagents, express cKit.
To this end, we would like to acknowledge many limitations of the knockin models compared with transgenic approaches, which may have influenced the cKit lineagetracing findings reported by us and others. 3, 5, 6 For example, coat color differences between the wild-type and cKit knockin mice likely suggest improper function of neural crest cells because of cKit haploinsufficiency. It is possible that this deficit also affected cardiac cKit + cells to some extent; therefore, our findings may have somewhat underestimated the role of cKit + cells in the heart. In summary, our findings indicate that postnatal CSCs are bona fide cardiomyogenic stem cells from which new cardiomyocytes are generated after birth. We further show that a biologically important relationship exists between MSCs and CSCs, which involves the SCF/cKit and the SDF1/CXCR4 pathways, and may be harnessed for therapeutically enhancing the degree of cardiomyogenesis from endogenous CSCs. Together these findings support the development of novel cell combination-based therapies for the prevention and treatment of heart disease. 
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What Is Known?
• Because bone marrow MSCs stimulate endogenous CSCs, the idea of mixing MSCs and CSCs to create a novel and potent cell-based therapeutic has arisen. • Although mixtures of MSCs and CSCs have enhanced therapeutic effects in porcine models, the precise molecular and cellular mechanisms for this interactive effect are not fully known.
What New Information Does This Article Contribute?
• Using organotypic coculturing and genetic labeling of CSCs, this study shows that MSCs stimulate profoundly the abundance and migration of CSCs.
• MSCs promote CSC proliferation via the SCF/cKit signaling axis.
• MSCs induce CSC migration and differentiation into de novo cardiomyocytes via regulation of the SDF1/CXCR4 signaling axis.
Summary
Combining MSC and CSCs is a potential means to augment therapeutic cell-based repair of the injured heart. Although animal models support the idea that these mixtures have enhanced efficacy to reduce infarct scar in acute myocardial infarction and enhance left ventricular performance in chronic heart failure, the mechanistic basis for MSC-CSC interactions action are incompletely understood. Here, we show that MSCs stimulate CSCs to proliferate, migrate, and differentiate in de novo cardiomyocytes, by regulating the SCF/cKit and SDF1/CXCR4 signaling pathways. Using iPSC modeling, we demonstrate that developmental activation of SDF1/CXCR4 signaling is involved in CSC specification, migration, and differentiation into Nkx2.5 + cardiomyocytes. Paradoxically, genetic lineage tracing in neonatal mice reveals loss of migratory and proliferative activity of postnatal CSCs, which may be recovered via MSC-dependent activation of SDF1/ CXCR4. Antagonism of MSC-mediated SDF1/CXCR4 signaling by AMD3100 inhibits postnatal CSC migration and proliferation but promotes differentiation into beating cardiomyocytes. On the other hand, SCF/cKit signaling enhances CSC proliferation but not migration. Human MSCs elicit similar effects in culture-expanded adult human CSCs. Together, these findings offer novel insights into the mechanisms of cell-based cardiac repair and support the concept that MSC-CSC interactions may be deployed therapeutically to enhance cardiac regenerative repair.
Supplemental Material. DETAILED METHODS.
Mice. The cKit
CreERT2/+ and IRG, mice that were employed in this study, have been previously
Tamoxifen-induced recombination. To induce CreER T2 -mediated recombination in cKit CreERT2 ;IRG neonates, tamoxifen (Sigma) was dissolved in peanut oil (Sigma) at a final concentration of 20mg/ml by shaking overnight at 37°C, and was administered via single subcutaneous injections (50µl/injection) at selected time points. For inducing CreER T2 -mediated recombination in-vitro, the active metabolite of tamoxifen, (Z)-4-hydroxytamoxifen (4-OH tamoxifen; Sigma), was dissolved in 100% ethanol (Sigma) and used at a final concentration of 1µM, supplemented in the culture medium.
Porcine MSC isolation, expansion and inactivation. Swine MSCs were isolated and expanded from a single, healthy Yorkshire donor as previously described (7, 44) . Briefly, bone marrow was obtained from the iliac crest, and aspirates were passed through a density gradient to eliminate undesired cell types and were plated with 25ml MEM Alpha media (Mediatech, 
Generation of CSCs from iPSC
kit . The generation of mouse iPSC kit has been previously described 1 . Differentiation into mouse CSCs was performed as previously described 1 . Briefly, Immunohistochemistry and confocal microscopy. Samples were fixed for 1-1.5 h in 4% PFA (EMS) at room temperature followed by overnight incubation in 30% sucrose (Calbiochem) at 4°C. Next day, samples were embedded in OCT (EMS) and flash-frozen in liquid nitrogen.
Cryosectioning was performed as previously described (46) . For immunohistochemistry, 10µm-thick samples were post-fixed for 10min with 4% PFA and blocked for 1h at RT with 10% normal donkey serum (Chemicon), followed by overnight incubation at 4°C with the primary antibody.
Subsequently, samples were visualized by incubating the sections for 1h at 37°C with FITC, Cy3 and Cy5-conjugated F(ab') 2 fragments of affinity-purified secondary antibodies (Jackson Immunoresearch) or Alexa 488 and Alexa 546 dyes (Molecular probes). The primary antibodies used were EGFP (1:500 dilution, Aves GFP-1020), Nkx2.5 (1:50 dilution, Santa Cruz Biotechnologies, SC-14033 and SC-8697), CD68 (1:100 dilution, Santa Cruz Biotechnologies, medium. The next day, the medium was replaced with 2ml of serum-free CXCR4-Chem1 cell medium (Millipore), and returned to the incubator for 24h. For the 96-well assay, 20µl of CXCR4-Chem1 hMSC-conditioned medium were used per well.
Statistics.
Statistical analyses were performed using GraphPad Prism version 5.00 for Windows. A twoway repeated measures ANOVA, followed by Bonferroni post-hoc tests, was employed for 
